StreetInsider.com News Articles

Lumexa Imaging forms joint venture with Hospital for Special Surgery

Tue, 02 Jun 2026 07:00:41 -0400

Lumexa Imaging (NASDAQ: LMRI) announced the formation of a joint venture with Hospital for Special Surgery to expand outpatient imaging services in the New York City metro area.

The collaboration represents Lumexa Imaging's ninth joint venture and aims to increase access to advanced outpatient imaging services across the region. The companies plan to bring imaging services closer to patients and referring providers in New York, which the press release describes as one of the nation's largest healthcare markets.

"Our collaboration with HSS represents an important milestone in Lumexa Imaging's continued growth," said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. "We are

Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York

Tue, 02 Jun 2026 07:00:00 -0400

This collaboration marks Lumexa Imaging’s ninth joint venture and advances the company’s health system growth strategy

RALEIGH, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced the formation of a strategic joint venture with Hospital for Special Surgery (HSS), world leader in musculoskeletal health.

The collaboration represents Lumexa Imaging’s ninth joint venture and further strengthens the company’s presence in New York—one of the nation’s largest healthcare markets. Lumexa Imaging and HSS plan to expand access to advanced outpatient imaging services across

Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York

Tue, 02 Jun 2026 07:00:00 -0400

This collaboration marks Lumexa Imaging’s ninth joint venture and advances the company’s health system growth strategy

Form 4 Lumexa Imaging Holdings, For: May 19 Filed by: BRODNAX BRETT

Thu, 21 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260521/26535724.html

Lumexa Imaging Holdings (LMRI) PT Lowered to $9 at Barclays

Wed, 20 May 2026 04:19:40 -0400

Barclays analyst Andrew Mok lowered the price target on Lumexa Imaging Holdings (NASDAQ: LMRI) to $9.00 (from $15.00) while maintaining a Overweight rating.

Form 4 Lumexa Imaging Holdings, For: May 14 Filed by: Cooper Henry Lee

Mon, 18 May 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260518/26513965.html

Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q1 EPS ; Offers Guidance

Wed, 13 May 2026 00:56:37 -0400

Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI) reported Q1 EPS of $0.18, in-line with the analyst estimate of $0.18. Revenue for the quarter came in at $252.54 million.

GUIDANCE:

Lumexa Imaging Holdings, Inc. sees FY2026 EPS of $0.71-$0.77, versus the consensus of $0.73. Lumexa Imaging Holdings, Inc. sees FY2026 revenue of $1.04-1.09 billion, versus the consensus of $1.07 billion.

For earnings history and earnings-related data on Lumexa Imaging Holdings, Inc. (LMRI) click here.

Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q1 EPS ; Offers Guidance

Wed, 13 May 2026 00:56:37 -0400

Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI) reported Q1 EPS of $0.18, in-line with the analyst estimate of $0.18. Revenue for the quarter came in at $252.54 million.

GUIDANCE:

For earnings history and earnings-related data on Lumexa Imaging Holdings, Inc. (LMRI) click here.

Form 10-Q Lumexa Imaging Holdings, For: Mar 31

Tue, 12 May 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260512/26478155.html

Form 8-K Lumexa Imaging Holdings, For: May 12

Tue, 12 May 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260512/26477842.html

Lumexa Imaging Announces First Quarter 2026 Results

Tue, 12 May 2026 16:07:00 -0400

RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 guidance.

“In Q1, we delivered several meaningful achievements to kick off a year of executing on our strategic priorities,” said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. “We continued to drive strong growth in same-center advanced imaging volumes and our de novo centers are ramping according to our plans.”

“We are also announcing tonight

Lumexa Imaging Announces First Quarter 2026 Results

Tue, 12 May 2026 16:07:00 -0400

“We are also announcing tonight

Lumexa Imaging adds four new outpatient centers across Southeast

Tue, 12 May 2026 16:06:09 -0400

Lumexa Imaging (NASDAQ: LMRI) announced the addition of four new imaging centers in 2026, located in Spartanburg, South Carolina; Concord, North Carolina; Wexford, Pennsylvania; and Niceville, Florida.

The company added two locations through acquisitions with joint venture partners Advocate Health and UPMC, while opening two new centers. The Wexford, Pennsylvania location represents the first contribution from Lumexa's joint venture with University of Pittsburgh Medical Center.

"Year to date, we have completed two acquisitions and opened two de novo centers, helping keep us on pace on our goal of delivering 8 to 10 de novos annually," said Caitlin Zulla, Chief Executive Officer of

Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers

Tue, 12 May 2026 16:05:00 -0400

Expansion across the Southeast and Mid-Atlantic includes entry into Pennsylvania through joint venture with University of Pittsburgh Medical Center (UPMC)

RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced the addition of four new locations in 2026 as part of its continued execution against a disciplined, multi-channel growth strategy. The new centers are located in Spartanburg, South Carolina; Concord, North Carolina; Wexford, Pennsylvania; and Niceville, Florida.

Two of the new locations were added through acquisitions with Lumexa Imaging’s joint venture

Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers

Tue, 12 May 2026 16:05:00 -0400

Expansion across the Southeast and Mid-Atlantic includes entry into Pennsylvania through joint venture with University of Pittsburgh Medical Center (UPMC)

Two of the new locations were added through acquisitions with Lumexa Imaging’s joint venture

Form ARS Lumexa Imaging Holdings, For: Dec 31

Tue, 28 Apr 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260428/26384853.html

Form DEFA14A Lumexa Imaging Holdings,

Tue, 28 Apr 2026 16:37:00 -0400

si-local-file:///var/storage/secattach/20260428/26384838.html

Form DEF 14A Lumexa Imaging Holdings, For: Jun 10

Tue, 28 Apr 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260428/26384809.html

Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date

Tue, 28 Apr 2026 16:15:00 -0400

RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET.

The live audio webcast will be available in the Investor Relations section of the Company’s website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one

Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date

Tue, 28 Apr 2026 16:15:00 -0400

The live audio webcast will be available in the Investor Relations section of the Company’s website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one

Lumexa Imaging names Kyle Lynch as chief growth officer

Mon, 20 Apr 2026 07:03:47 -0400

Lumexa Imaging (NASDAQ: LMRI) appointed Kyle Lynch as chief growth officer, the outpatient imaging services provider announced April 20. Lynch will lead the company's growth strategy, including joint ventures, acquisitions and new location development.

In his role, Lynch will oversee growth initiatives from opportunity identification through transaction execution and integration. He will work with senior leadership to align expansion efforts with operational and financial objectives.

"Kyle brings a powerful combination of strategic insight, execution discipline, and commercial leadership," said Caitlin Zulla, chief executive officer of Lumexa Imaging.

Lynch will also lead the company's Sales Center of Excellence, focusing on sales productivity, performance metrics

Lumexa Imaging names Kyle Lynch as chief growth officer

Mon, 20 Apr 2026 07:03:47 -0400

"Kyle brings a powerful combination of strategic insight, execution discipline, and commercial leadership," said Caitlin Zulla, chief executive officer of Lumexa Imaging.

Lynch will also lead the company's Sales Center of Excellence, focusing on sales productivity, performance metrics

Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

Mon, 20 Apr 2026 07:00:00 -0400

RALEIGH, N.C., April 20, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced the appointment of Kyle Lynch as its new Chief Growth Officer (CGO). Lynch joins the executive leadership team to lead the company’s enterprise growth strategy, with responsibility for expanding Lumexa Imaging’s platform through joint ventures, acquisitions, and de novo development.

In this role, Lynch will oversee the full growth lifecycle, including opportunity origination, transaction execution, and post-close value realization, with a focus on driving sustainable, profitable growth and

Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

Mon, 20 Apr 2026 07:00:00 -0400

Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

Mon, 20 Apr 2026 07:00:00 -0400